Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressive ERG fusion-positive prostate cancers (Q39136055)

From Wikidata

Jump to navigation Jump to search

scientific article published on September 2013

Language	Label	Description	Also known as
English	Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressive ERG fusion-positive prostate cancers	scientific article published on September 2013

Statements

scholarly article

1 reference

Europe PubMed Central

9 September 2017

Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressive ERG fusion-positive prostate cancers (English)

1 reference

Europe PubMed Central

9 September 2017

prostate cancer

1 reference

based on heuristic

inferred from title

11

object named as

Hartwig Huland

1 reference

Europe PubMed Central

9 September 2017

author name string

Antje Krohn

1

1 reference

Europe PubMed Central

9 September 2017

Annemarie Seidel

2

1 reference

Europe PubMed Central

9 September 2017

Lia Burkhardt

3

1 reference

Europe PubMed Central

9 September 2017

Frederic Bachmann

4

1 reference

Europe PubMed Central

9 September 2017

Malte Mader

5

1 reference

Europe PubMed Central

9 September 2017

Katharina Grupp

6

1 reference

Europe PubMed Central

9 September 2017

Till Eichenauer

7

1 reference

Europe PubMed Central

9 September 2017

Andreas Becker

8

1 reference

Europe PubMed Central

9 September 2017

Meike Adam

9

1 reference

Europe PubMed Central

9 September 2017

Markus Graefen

10

1 reference

Europe PubMed Central

9 September 2017

Stefan Kurtz

12

1 reference

Europe PubMed Central

9 September 2017

Stefan Steurer

13

1 reference

Europe PubMed Central

9 September 2017

Maria C Tsourlakis

14

1 reference

Europe PubMed Central

9 September 2017

Sarah Minner

15

1 reference

Europe PubMed Central

9 September 2017

Uwe Michl

16

1 reference

Europe PubMed Central

9 September 2017

Thorsten Schlomm

17

1 reference

Europe PubMed Central

9 September 2017

Guido Sauter

18

1 reference

Europe PubMed Central

9 September 2017

Ronald Simon

19

1 reference

Europe PubMed Central

9 September 2017

Hüseyin Sirma

20

1 reference

Europe PubMed Central

9 September 2017

publication date

1 September 2013

1 reference

Europe PubMed Central

9 September 2017

Journal of Pathology

1 reference

Europe PubMed Central

9 September 2017

231

1 reference

Europe PubMed Central

9 September 2017

1

1 reference

Europe PubMed Central

9 September 2017

130-141

1 reference

Europe PubMed Central

9 September 2017

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1002%2FPATH.4223

21 January 2018

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2FPATH.4223

21 January 2018

Distinct genomic alterations in prostate cancers in Chinese and Western populations suggest alternative pathways of prostate carcinogenesis.

1 reference

https://api.crossref.org/works/10.1002%2FPATH.4223

21 January 2018

A variant TMPRSS2 isoform and ERG fusion product in prostate cancer with implications for molecular diagnosis.

1 reference

https://api.crossref.org/works/10.1002%2FPATH.4223

21 January 2018

Genomic profiling reveals alternative genetic pathways of prostate tumorigenesis

1 reference

https://api.crossref.org/works/10.1002%2FPATH.4223

21 January 2018

Genomic deletion of MAP3K7 at 6q12-22 is associated with early PSA recurrence in prostate cancer and absence of TMPRSS2:ERG fusions

1 reference

https://api.crossref.org/works/10.1002%2FPATH.4223

21 January 2018

Identification of novel CHD1-associated collaborative alterations of genomic structure and functional assessment of CHD1 in prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPATH.4223

21 January 2018

CHD1 is a 5q21 tumor suppressor required for ERG rearrangement in prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2FPATH.4223

21 January 2018

Integrative genomic profiling of human prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPATH.4223

21 January 2018

FOXP1: a potential therapeutic target in cancer.

1 reference

https://api.crossref.org/works/10.1002%2FPATH.4223

21 January 2018

Expression of the forkhead transcription factor FOXP1 is associated with estrogen receptor alpha and improved survival in primary human breast carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FPATH.4223

21 January 2018

FOXP1 is an androgen-responsive transcription factor that negatively regulates androgen receptor signaling in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FPATH.4223

21 January 2018

Truncated ETV1, fused to novel tissue-specific genes, and full-length ETV1 in prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2FPATH.4223

21 January 2018

Neurovascular structure-adjacent frozen-section examination (NeuroSAFE) increases nerve-sparing frequency and reduces positive surgical margins in open and robot-assisted laparoscopic radical prostatectomy: experience after 11,069 consecutive patien

1 reference

https://api.crossref.org/works/10.1002%2FPATH.4223

21 January 2018

FISH Oracle: a web server for flexible visualization of DNA copy number data in a genomic context.

1 reference

https://api.crossref.org/works/10.1002%2FPATH.4223

21 January 2018

Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma

1 reference

https://api.crossref.org/works/10.1002%2FPATH.4223

21 January 2018

ERG status is unrelated to PSA recurrence in radically operated prostate cancer in the absence of antihormonal therapy.

1 reference

https://api.crossref.org/works/10.1002%2FPATH.4223

21 January 2018

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

1 reference

https://api.crossref.org/works/10.1002%2FPATH.4223

21 January 2018

Low level HER2 overexpression is associated with rapid tumor cell proliferation and poor prognosis in prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPATH.4223

21 January 2018

Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPATH.4223

21 January 2018

Expression of the forkhead transcription factor FOXP1 is associated both with hypoxia inducible factors (HIFs) and the androgen receptor in prostate cancer but is not directly regulated by androgens or hypoxia

1 reference

https://api.crossref.org/works/10.1002%2FPATH.4223

21 January 2018

A transcriptional repressor co-regulatory network governing androgen response in prostate cancers

1 reference

https://api.crossref.org/works/10.1002%2FPATH.4223

21 January 2018

An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression

1 reference

https://api.crossref.org/works/10.1002%2FPATH.4223

21 January 2018

ETS transcription factors control transcription of EZH2 and epigenetic silencing of the tumor suppressor gene Nkx3.1 in prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPATH.4223

21 January 2018

Nuclear receptor-induced chromosomal proximity and DNA breaks underlie specific translocations in cancer

1 reference

https://api.crossref.org/works/10.1002%2FPATH.4223

21 January 2018

Induced chromosomal proximity and gene fusions in prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPATH.4223

21 January 2018

Chromatin replication and epigenome maintenance

1 reference

https://api.crossref.org/works/10.1002%2FPATH.4223

21 January 2018

Haplo-insufficiency: a driving force in cancer

1 reference

https://api.crossref.org/works/10.1002%2FPATH.4223

21 January 2018

PCGF homologs, CBX proteins, and RYBP define functionally distinct PRC1 family complexes

1 reference

https://api.crossref.org/works/10.1002%2FPATH.4223

21 January 2018

RYBP-PRC1 complexes mediate H2A ubiquitylation at polycomb target sites independently of PRC2 and H3K27me3

1 reference

https://api.crossref.org/works/10.1002%2FPATH.4223

21 January 2018

RYBP stabilizes p53 by modulating MDM2

1 reference

https://api.crossref.org/works/10.1002%2FPATH.4223

21 January 2018

The H/ACA RNP assembly factor SHQ1 functions as an RNA mimic

1 reference

https://api.crossref.org/works/10.1002%2FPATH.4223

21 January 2018

SHQ1 is required prior to NAF1 for assembly of H/ACA small nucleolar and telomerase RNPs

1 reference

https://api.crossref.org/works/10.1002%2FPATH.4223

21 January 2018

The genomic complexity of primary human prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPATH.4223

21 January 2018

Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPATH.4223

21 January 2018

The mutational landscape of lethal castration-resistant prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPATH.4223

21 January 2018

Identification of glycosyltransferase 8 family members as xylosyltransferases acting on O-glucosylated notch epidermal growth factor repeats

1 reference

https://api.crossref.org/works/10.1002%2FPATH.4223

21 January 2018

Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth

1 reference

https://api.crossref.org/works/10.1002%2FPATH.4223

21 January 2018

Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway

1 reference

https://api.crossref.org/works/10.1002%2FPATH.4223

21 January 2018

PML isoforms I and II participate in PML-dependent restriction of HSV-1 replication

1 reference

https://api.crossref.org/works/10.1002%2FPATH.4223

21 January 2018

Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome

1 reference

https://api.crossref.org/works/10.1002%2FPATH.4223

21 January 2018

Genomic Deletion of PTEN Is Associated with Tumor Progression and Early PSA Recurrence in ERG Fusion-Positive and Fusion-Negative Prostate Cancer

1 reference

https://api.crossref.org/works/10.1002%2FPATH.4223

21 January 2018

Identifiers

10.1002/PATH.4223

1 reference

Europe PubMed Central

9 September 2017

1 reference

Europe PubMed Central

9 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39136055&oldid=1856178921"